GlobeNewswire·Aug 4, 2026, 8:00 AM ET

YD Bio Highlights Peer-Reviewed Publication on New Computational Framework for Keratoconus Research

YD Bio Limited co-authored a peer-reviewed study with Taipei Medical University researchers published in the journal Bioengineering on August 4, 2026.
The study identifies key molecular candidates to guide regenerative therapies for keratoconus, a common corneal disorder lacking treatments for underlying molecular causes.
Researchers developed a computational framework called the Cargo Prioritization Score (CPS) to analyze public gene and protein databases and rank potential therapeutic targets.
The resulting shortlist of candidate molecules includes proteins such as COL1A1, FN1, COL4A1, COL3A1, COL5A1, & MMP1.
The research is designed to generate hypotheses for future laboratory validation rather than establishing clinical safety or efficacy of any specific therapeutic products.
Dr. Ethan Shen, Founder, Chairman, & CEO of YD Bio, contributed as a co-author to this cross-sector collaboration involving industry, clinical medicine, & academia.
The open-access article is freely available in Bioengineering (2026, Vol. 13, Article 853) with the DOI 10.3390/bioengineering13080853.